Subcutaneous Levetiracetam for the Management of Seizures at the End of Life: An Audit and Updated Literature Review.

Sutherland, Anna; Meldon, Charlotte; Harrison, Timothy; Miller, Mary

Sutherland, Anna; Meldon, Charlotte; Harrison, Timothy; Miller, Mary.

Afiliação

Sutherland A; Department of Palliative Medicine, Michael Sobell House Hospice, Churchill Hospital, Oxford, United Kingdom.
Meldon C; Department of Palliative Medicine, Michael Sobell House Hospice, Churchill Hospital, Oxford, United Kingdom.
Harrison T; Department of Palliative Medicine, Michael Sobell House Hospice, Churchill Hospital, Oxford, United Kingdom.
Miller M; Department of Palliative Medicine, Michael Sobell House Hospice, Churchill Hospital, Oxford, United Kingdom.

J Palliat Med ; 24(7): 976-981, 2021 07.

Article em En | MEDLINE | ID: mdl-33296254

Assuntos

Piracetam; Anticonvulsivantes/uso terapêutico; Morte; Humanos; Levetiracetam/uso terapêutico; Piracetam/uso terapêutico; Estudos Retrospectivos; Convulsões/tratamento farmacológico

Palavras-chave

pharmacology; symptom control (other than pain)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Piracetam Tipo de estudo: Observational_studies Aspecto: Ethics Limite: Humans Idioma: En Revista: J Palliat Med Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google